As a result, roflumilast, a selective inhibitor of phosphodiesterase-4 (PDE-4) that promotes BDNF expression and alleviates depression-induced neuronal injury and apoptosis, induces CREB phosphorylation, similar to Zhang et al. [46]. Here, PDE4A is linked to major depressive disorder.